Several other research firms also recently commented on TRUP. Northland Securities reissued a buy rating and issued a $40.00 price objective on shares of Trupanion in a report on Wednesday, July 31st. Zacks Investment Research downgraded Trupanion from a hold rating to a sell rating in a report on Friday, August 2nd. TheStreet downgraded Trupanion from a c rating to a d+ rating in a report on Tuesday, July 30th. Guggenheim assumed coverage on Trupanion in a report on Thursday, May 23rd. They set a buy rating and a $35.00 price target for the company. Finally, Craig Hallum downgraded Trupanion from a buy rating to a hold rating and set a $29.00 price target for the company. in a report on Friday, August 16th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $37.50.
Shares of NASDAQ TRUP traded up $0.50 during trading hours on Thursday, hitting $27.06. The company had a trading volume of 8,323 shares, compared to its average volume of 344,580. The stock has a market capitalization of $879.84 million, a P/E ratio of -905.00 and a beta of 1.47. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.15. Trupanion has a 1-year low of $22.38 and a 1-year high of $37.39. The firm’s 50 day moving average is $27.99 and its 200-day moving average is $31.32.
Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Tuesday, July 30th. The financial services provider reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.03). The company had revenue of $92.20 million during the quarter, compared to analyst estimates of $91.17 million. Trupanion had a negative net margin of 0.68% and a negative return on equity of 1.77%. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.01) EPS. On average, sell-side analysts predict that Trupanion will post -0.12 earnings per share for the current year.
In other Trupanion news, CRO Margaret Tooth sold 750 shares of the firm’s stock in a transaction on Tuesday, June 18th. The stock was sold at an average price of $34.69, for a total transaction of $26,017.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Darryl Rawlings sold 4,000 shares of the stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $36.48, for a total value of $145,920.00. Following the transaction, the insider now owns 1,523,120 shares in the company, valued at approximately $55,563,417.60. The disclosure for this sale can be found here. Insiders have sold a total of 26,450 shares of company stock valued at $815,808 in the last ninety days. Insiders own 13.61% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Manchester Capital Management LLC increased its position in Trupanion by 100.9% during the 1st quarter. Manchester Capital Management LLC now owns 1,710 shares of the financial services provider’s stock worth $56,000 after buying an additional 859 shares during the period. Aperio Group LLC bought a new position in Trupanion during the 2nd quarter worth $166,000. BNP Paribas Arbitrage SA increased its position in Trupanion by 1,247.2% during the 1st quarter. BNP Paribas Arbitrage SA now owns 5,362 shares of the financial services provider’s stock worth $176,000 after buying an additional 4,964 shares during the period. US Bancorp DE increased its position in Trupanion by 6.0% during the 2nd quarter. US Bancorp DE now owns 6,145 shares of the financial services provider’s stock worth $222,000 after buying an additional 350 shares during the period. Finally, Angeles Investment Advisors LLC bought a new position in Trupanion during the 1st quarter worth $246,000. Hedge funds and other institutional investors own 96.34% of the company’s stock.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Recommended Story: Systematic Risk
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.